Navigation Links
China Medical Technologies to Present at Jefferies 2011 Global Healthcare Conference on June 7, 2011
Date:5/6/2011

BEIJING, May 6, 2011 /PRNewswire-Asia-FirstCall/ --  China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that Mr. Sam Tsang, the Company's Chief Financial Officer will present at Jefferies 2011 Global Healthcare Conference in New York at 12:45pm on June 7, 2011 and will meet institutional investors at the conference throughout the date.  He will travel to Boston, Chicago and Los Angeles to meet institutional investors during the rest of the week.  Mr. David Chung, the Company's Financial Controller and Ms. Winnie Yam, the Company's Investor Relations Manager will participate in Bank of America Merrill Lynch HK China Healthcare Corporate Day in Hong Kong on June 8, 2011.

About China Medical Technologies, Inc.China Medical Technologies, Inc. is a leading China-based advanced IVD company using molecular diagnostic technologies including Fluorescent in situ Hybridization (FISH) and Surface Plasmon Resonance (SPR) and an immunodiagnostic technology, Enhanced Chemiluminescence Immunoassay (ECLIA), to develop, manufacture and distribute diagnostic products used for the detection of various cancers, diseases and disorders as well as companion diagnostic tests for targeted cancer drugs. The Company generates all of its revenues in China through the sale of diagnostic consumables including FISH probes, SPR-based DNA chips and ECLIA reagent kits to hospitals which are recurring users of the consumables for their patients. The Company sells FISH probes and SPR chips to large hospitals through its direct sales personnel and ECLIA reagent kits to small and mid-size hospitals through distributors. For more information, please visit http://www.chinameditech.com.ContactWinnie YamTel: 852-2511-9808Email:

SOURCE China Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. ThermoGenesis Reports Third Quarter Fiscal 2011 Results; Major Progress Achieved in China & India
2. China Sky One Medical Announces Conference Call to Discuss First Quarter 2011 Results
3. ICSE China to Offer Inaugural Conference Programme in 2011
4. Transgenomic, Inc. Presents Its Latest Technology at the BIT Life Sciences World DNA and Genome Day Conference, Dalian, China
5. China Medical Technologies to Announce Results for the Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2011 on June 2, 2011
6. China Botanic Pharmaceutical Announces Plans to Switch to Renewable Bio-Fuel - Straw Pellets
7. China Shenghuo Announces New Chief Financial Officer
8. Tens of thousands of buyers including Coles Group, El Corte Ingles, Kingfisher, Sears, The Home Depot and Tesco registered to attend China Sourcing Fairs
9. Medical Care Technologies Inc. Signs Letter of Intent for Joint Venture in China
10. China Botanic Pharmaceutical Provides Update on Badger Oil Sales
11. Varian Medical Systems to Exhibit the Latest Digital Image Detectors, X-Ray Tubes and Cancer Treatment Technologies at the CMEF Show in Shenzhen, China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013   Voices Against Brain ... a cure for brain cancer, today announced that it ... to support the clinical investigation of Toca 511 & ... grade glioma brain cancer (Grade 3 or Grade 4).  ... treatments for advanced cancer, with an initial focus on ...
(Date:6/19/2013)... --  Nektar Therapeutics (Nasdaq: NKTR ) today ... study for NKTR-181, a first-in-class, opioid analgesic molecule ... slow rate of entry is designed to reduce the euphoria ... current opioid analgesics. 1 In the study data being ... in "drug liking" and "feeling high" scores and had highly ...
(Date:6/19/2013)... , June 19, 2013 NeuroDerm, ... study in volunteers, and preliminary results from a phase ... presented at the 2013 International Congress of Parkinson,s Disease ... drug formula under development for continuous administration through a ... plasma concentrations. ND0612 has been shown in ...
Breaking Medicine Technology:Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 2Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 4Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 5Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 6Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 7Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 8Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 9NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6
... (Pink Sheets: SNDY) is pleased to announce that its ... at the 95th Annual American College of Surgeons Clinical ... the Breast Ductoscopy for the General Surgeon course, postgraduate ... skill stations that will provide the core knowledge base ...
... SAN RAMON, Calif., Oct. 7 Odyssey Thera, Inc. ... of its investors, Pfizer Inc. following Pfizer,s decision to ... of Odyssey,s multi-year alliance with Pfizer announced in August, ... to be earned for the advancement of specific drug ...
Cached Medicine Technology:Solos Endoscopy, Inc.'s MammoView(TM) Product Line to be Demonstrated at the 95th Annual American College of Surgeons Clinical Congress 2
(Date:6/19/2013)... June 19, 2013 Strict rules ... July 2013, Orriant is launching a new tool ... maintain compliance with regulations. New HHS regulations ... wellness incentives if their employer offers outcome-based, health-contingent, ... been compliant with these standards for nearly a ...
(Date:6/19/2013)... 19, 2013 As Januvia lawsuit ... to mount in courts throughout the U.S., Bernstein Liebhard ... (FDA) recently held a meeting to discuss the safety ... mimetics. According to a June 12th report from ... makers of Januvia and similar drugs, following a recent ...
(Date:6/19/2013)... what is believed to be the largest follow-up record ... dystonia a movement disorder that can cause crippling ... good success rates and lasting benefits. , Michele Tagliati, ... Cedars-Sinai Medical Center,s Department of Neurology, and Ron L. ... Beth Israel Deaconess Medical Center in Boston, published the ...
(Date:6/19/2013)... reveals significant disparities between minority and white clients ... programs. Moreover, these disparities vary widely from state ... for most states there,s something amiss," says Stephan ... "There are strong racial and ethnic disparities for ... treatment programs successfully, and those disparities are something ...
(Date:6/19/2013)... 2013 The Movement Disorders ... psychiatrists and urologists with specialists in physical therapy, ... with patients and their family members to manage ... life. Patients also have the opportunity to participate ... , “Movement disorders can be relentlessly progressive and ...
Breaking Medicine News(10 mins):Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 3Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 2Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 3Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2Health News:States vary widely on success rates for minorities in drug treatment programs 2Health News:States vary widely on success rates for minorities in drug treatment programs 3Health News:Abington Memorial Hospital’s Neurosciences Institute Opens Movement Disorders Center 2
... finds that almost half of the U.S. population possesses a ... of developing diabetes. // ,Diabetes is one of the ... many other complications. Genes are one among the many factors ... assistant professor of nutrition and dietetics at Doisy College of ...
... healthy eating habits, teens in middle adolescence are eating ... study reveals.// And the situation only worsens as teens ... important for the prevention of future chronic disease,” said ... it’s important to know whether intakes of teens are ...
... Louis University researcher confirms findings that about half of the ... them to metabolize food// differently, putting them at greater risk ... professor of nutrition and dietetics at Doisy College of Health ... version of a gene called FABP2, which is involved in ...
... the University of California, San Diego has found what ... promote cancer. The findings// may provide a new approach ... that what scientists thought were two distinct processes in ... dangers such as invading organisms—are actually linked. The researchers, ...
... Center-led study has shown conclusively that a neuropeptide, melanin ... for its role in// increasing appetite in people, plays ... and the secretion of insulin. This finding has the ... diabetes that stimulate the production of insulin-producing beta cells ...
... physicians predicts early risk of stroke following a serious condition ... a "mini-stroke," according to a study. ,About ... and about 70,000 in the United Kingdom. A TIA is ... oxygen supply to part of the brain that can cause ...
Cached Medicine News:Health News:Today’s Teens Slacking on Fruit, Veggie Intak 2Health News:Molecular Link Between Inflammation and Cancer Discovered 2Health News:Molecular Link Between Inflammation and Cancer Discovered 3Health News:Role of Appetite Hormone MCH in Insulin Production Revealed 2Health News:New Tool Improves Prediction of Stroke Risk 2
The Foundation PS knee offers a femoral option and tibial insert which provides a specially designed cam action that engages at 60 degrees of flexion to induce a smooth stable femoral roll-back motio...
... Natural Knee design includes several ... CSTi porous coating option for ... a unique bone preserving posterior ... groove to maximize range of ...
... Total Knee System provides anatomical replacement of ... while preserving the stabilizing Anterior and Posterior ... motion of the knee. All the components ... sizes and are equally proportioned and contoured ...
Advance Posterior Stabilized Total Knee systems improves patellofemoral kinematics, reduces wear rate potential, increases resistance to posterior tibial dislocation, achieves at least 120o flexion i...
Medicine Products: